Form D · Biotechnology
Mammogen, Inc.
Aliso Viejo, CA · CIK 0001832269
Offering snapshot reported Nov 16, 2020 · SEC filing
- Reported sold
- $25K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 9, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2020 | Initial | $25,003 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380600
Source: Form D, filed Nov 16, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Denise De Man | Director |
| Martin J Keiser Iii | Director, Executive |
| Patrick Lilley | Director |
| Roland Muduryan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 B Liberty Suite 228
Aliso Viejo, CA, 92656
Aliso Viejo, CA, 92656